⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DNLI News
Denali Therapeutics Inc. Common Stock
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH⢠(tividenofusp alfa-eknm)
prnewswire.com
DNLI
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
globenewswire.com
SRPT
ALNY
DNLI
ARCT
Courier Health Releases 2026 State of Patient-Centricity in Biopharma Report
prnewswire.com
AZN
DNLI
GNE
PFE
UCB
Form 8-K
sec.gov
DNLI
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
globenewswire.com
DNLI
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
prnewswire.com
PRME
IOVA
MDGL
DNLI
Form 8-K
sec.gov
DNLI
Form 8-K
sec.gov
DNLI
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH⢠(tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
globenewswire.com
DNLI
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
prnewswire.com
PRME
IOVA
MDGL
DNLI